Skip to main content
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 3/2022

01.07.2022 | Original Contributions

Predictors of right ventricular pacing-induced left ventricular dysfunction in pacemaker recipients with preserved ejection fraction

verfasst von: Mohamed Abdelmohsen Sayed, Haitham Abd El Fatah Badran, Said Khaled, Emad Effat Fakhry

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Pacing is an effective treatment in the management of patients with bradyarrhythmias. Chronic right ventricular pacing may cause electrical and mechanical dyssynchrony leading to a deterioration of left ventricular ejection fraction (LVEF). This deterioration of LVEF has been described as pacing-induced cardiomyopathy (PICM). The incidence of PICM has been described by many studies, ranging between 10% and 26%. Predictors for PICM are not yet established—studies were limited by variations in the definition of PICM and the follow-up period. The authors studied the incidence and predictors of PICM in patients with preserved LVEF who underwent pacemaker implantation.

Patients and methods

This retrospective study included 320 patients that underwent single- or dual-chamber pacemaker implantation, with a mean follow up period of 4.7 ± 2.0 years. Implantable cardioverter defibrillator and cardiac resynchronization therapy patients were excluded from this study. Individuals that had a baseline LVEF ≥ 50% before implantation in transthoracic echocardiography were included in the study.

Results

Of the 320 patients included in the study, 45% were male, with a mean age 55.5 years. The incidence of PICM was 7.5%. Wider native QRS duration, particularly > 140 ms (P < 0.001), wider paced QRS (pQRS) duration > 150 ms (P < 0.001), low normal ejection fraction < 56% pre-implantation (P = 0.023) and increased LV end diastolic diameter (LVEDD) > 53 mm and LV end systolic diameter (LVESD) > 38 mm (P < 0.001) predicted the development of PICM. There was no association between burden of right ventricular pacing (P = 0.782) or pacing site (P = 0.876) and the development of pacemaker-induced cardiomyopathy.

Conclusion

Right ventricular pacing-induced left ventricular dysfunction is not uncommon, with an incidence of 7.5%. Wider native and paced QRS durations, low normal ejection fraction (< 56%) pre-implantation and increased LVEDD and LVESD post implantation are the most important predictors for the development of PICM.
Literatur
1.
Zurück zum Zitat Chen L, Hodge D, Jahangir A et al (2008) Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation. J Cardiovasc Electrophysiol 19:19–27CrossRef Chen L, Hodge D, Jahangir A et al (2008) Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation. J Cardiovasc Electrophysiol 19:19–27CrossRef
2.
Zurück zum Zitat Khurshid S, Epstein AE, Verdino RJ et al (2014) Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm 11:1619–1625CrossRef Khurshid S, Epstein AE, Verdino RJ et al (2014) Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm 11:1619–1625CrossRef
3.
Zurück zum Zitat Merchant FM, Mittal S (2018) Pacing-induced cardiomyopathy. Card Electrophysiol Clin 10:437–445CrossRef Merchant FM, Mittal S (2018) Pacing-induced cardiomyopathy. Card Electrophysiol Clin 10:437–445CrossRef
4.
Zurück zum Zitat Lee SA, Cha MJ, Cho Y et al (2016) Paced QRS duration and myocardial scar amount: predictors of long-term outcome of right ventricular apical pacing. Heart Vessels 31:1131–1139CrossRef Lee SA, Cha MJ, Cho Y et al (2016) Paced QRS duration and myocardial scar amount: predictors of long-term outcome of right ventricular apical pacing. Heart Vessels 31:1131–1139CrossRef
5.
Zurück zum Zitat Kim JH, Kang KW, Chin JY et al (2018) Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: a multicenter, retrospective analysis over a 15-year period in South Korea. BMJ Open 8:e19048CrossRef Kim JH, Kang KW, Chin JY et al (2018) Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: a multicenter, retrospective analysis over a 15-year period in South Korea. BMJ Open 8:e19048CrossRef
6.
Zurück zum Zitat Ebert M, Jander N, Minners J et al (2016) Long-term impact of right ventricular pacing on left ventricular systolic function in pacemaker recipients with preserved ejection fraction: results from a large single-center registry. J Am Heart Assoc 5:e3485CrossRef Ebert M, Jander N, Minners J et al (2016) Long-term impact of right ventricular pacing on left ventricular systolic function in pacemaker recipients with preserved ejection fraction: results from a large single-center registry. J Am Heart Assoc 5:e3485CrossRef
7.
Zurück zum Zitat Ng AC, Allman C, Vidaic J et al (2009) Long-term impact of right ventricular septal versus apical pacing on left ventricular synchrony and function in patients with second- or third-degree heart block. Am J Cardiol 103:1096–1101CrossRef Ng AC, Allman C, Vidaic J et al (2009) Long-term impact of right ventricular septal versus apical pacing on left ventricular synchrony and function in patients with second- or third-degree heart block. Am J Cardiol 103:1096–1101CrossRef
8.
Zurück zum Zitat Kiehl EL, Makki T, Kumar R et al (2016) Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm 13:2272–2278CrossRef Kiehl EL, Makki T, Kumar R et al (2016) Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm 13:2272–2278CrossRef
9.
Zurück zum Zitat Kaye GC, Linker NJ, Marwick TH et al (2015) Effect of right ventricular pacing lead site on left ventricular function in patients with high grade atrioventricular block: results of the Protect-Pace study. Eur Heart J 36:856–862CrossRef Kaye GC, Linker NJ, Marwick TH et al (2015) Effect of right ventricular pacing lead site on left ventricular function in patients with high grade atrioventricular block: results of the Protect-Pace study. Eur Heart J 36:856–862CrossRef
10.
Zurück zum Zitat Bansal R, Parakh N, Gupta A et al (2019) Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites. J Interv Card Electrophysiol 56(1):63–70CrossRef Bansal R, Parakh N, Gupta A et al (2019) Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites. J Interv Card Electrophysiol 56(1):63–70CrossRef
11.
Zurück zum Zitat Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937CrossRef Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937CrossRef
Metadaten
Titel
Predictors of right ventricular pacing-induced left ventricular dysfunction in pacemaker recipients with preserved ejection fraction
verfasst von
Mohamed Abdelmohsen Sayed
Haitham Abd El Fatah Badran
Said Khaled
Emad Effat Fakhry
Publikationsdatum
01.07.2022
Verlag
Springer Medizin
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 3/2022
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-022-00880-w

Weitere Artikel der Ausgabe 3/2022

Herzschrittmachertherapie + Elektrophysiologie 3/2022 Zur Ausgabe

Neuigkeiten aus der Young EP

Neuigkeiten aus der Young EP

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.